Donna Reidlinger

1.8k total citations
16 papers, 117 citations indexed

About

Donna Reidlinger is a scholar working on Nephrology, Hematology and Economics and Econometrics. According to data from OpenAlex, Donna Reidlinger has authored 16 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 4 papers in Hematology and 4 papers in Economics and Econometrics. Recurrent topics in Donna Reidlinger's work include Dialysis and Renal Disease Management (6 papers), Erythropoietin and Anemia Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Donna Reidlinger is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Erythropoietin and Anemia Treatment (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Donna Reidlinger collaborates with scholars based in Australia, New Zealand and United States. Donna Reidlinger's co-authors include Carmel M. Hawley, David W. Johnson, Stephen P. McDonald, Alan Cass, Vlado Perkovic, Sunil V. Badve, Liza A. Vergara, Rowan G. Walker, Philip Clarke and Anish Scaria and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Donna Reidlinger

15 papers receiving 116 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Reidlinger Australia 8 43 31 22 21 15 16 117
Chanel Prestidge New Zealand 8 53 1.2× 32 1.0× 15 0.7× 21 1.0× 13 0.9× 19 215
Anna Medyńska Poland 10 109 2.5× 14 0.5× 12 0.5× 8 0.4× 16 1.1× 31 233
Charlotte Tu United States 6 120 2.8× 32 1.0× 18 0.8× 16 0.8× 14 0.9× 16 234
Aseem Bharat United States 8 46 1.1× 30 1.0× 20 0.9× 20 1.0× 20 1.3× 10 182
Guillermo Martín-Reyes Spain 4 97 2.3× 18 0.6× 21 1.0× 6 0.3× 17 1.1× 12 134
Yannick Mayamba Nlandu Democratic Republic of the Congo 7 86 2.0× 8 0.3× 11 0.5× 13 0.6× 23 1.5× 33 168
Euan Noble Australia 5 77 1.8× 36 1.2× 19 0.9× 23 1.1× 6 0.4× 7 129
Edita Žiginskienė Lithuania 6 77 1.8× 24 0.8× 9 0.4× 13 0.6× 4 0.3× 25 139
Annalisa Pitino Italy 8 6 0.1× 28 0.9× 13 0.6× 7 0.3× 11 0.7× 24 143
Jean Robert Makulo Democratic Republic of the Congo 9 146 3.4× 37 1.2× 6 0.3× 70 3.3× 9 0.6× 18 249

Countries citing papers authored by Donna Reidlinger

Since Specialization
Citations

This map shows the geographic impact of Donna Reidlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Reidlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Reidlinger more than expected).

Fields of papers citing papers by Donna Reidlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Reidlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Reidlinger. The network helps show where Donna Reidlinger may publish in the future.

Co-authorship network of co-authors of Donna Reidlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Reidlinger. A scholar is included among the top collaborators of Donna Reidlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Reidlinger. Donna Reidlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Collins, Michael G., Magid Fahim, Elaine M. Pascoe, et al.. (2022). Baseline Characteristics and Representativeness of the BEST-Fluids Trial Participants: A Randomized Trial of Balanced Crystalloid Solution vs. Saline in Deceased Donor Kidney Transplantation. Journal of the American Society of Nephrology. 33(11S). 971–971. 1 indexed citations
3.
Reidlinger, Donna, David W. Johnson, Jonathan C. Craig, et al.. (2022). Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning. Kidney International. 102(6). 1222–1227. 1 indexed citations
4.
Jauré, Allison, Nicole Scholes‐Robertson, Kirsten Howard, et al.. (2022). Australian Workshops on Patients’ Perspectives on Hemodialysis and Incremental Start. Kidney International Reports. 8(3). 478–488. 3 indexed citations
5.
Scholes‐Robertson, Nicole, Martin Howell, Simon Carter, et al.. (2022). Perspectives of a proposed patient navigator programme for people with chronic kidney disease in rural communities: Report from national workshops. Nephrology. 27(11). 886–896. 8 indexed citations
6.
Éthier, Isabelle, Neil Boudville, Stephen P. McDonald, et al.. (2021). Representativeness of the PDOPPS cohort compared to the Australian PD population. Peritoneal Dialysis International. 42(4). 403–414. 2 indexed citations
7.
Bose, Bhadran, Sunil V. Badve, David W. Johnson, et al.. (2021). Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region. Nephrology. 27(1). 35–43. 1 indexed citations
10.
Gutman, Talia, Allison Tong, Martin Howell, et al.. (2019). Principles and strategies for involving patients in research in chronic kidney disease: report from national workshops. Nephrology Dialysis Transplantation. 35(9). 1585–1594. 14 indexed citations
11.
Duncanson, Emily, Kathryn Dansie, Talia Gutman, et al.. (2019). ‘Knowledge is power’: A framework for partnering with consumers in developing and delivering a scientific meeting in nephrology. Nephrology. 25(5). 379–383. 6 indexed citations
12.
Gummer, Joel P. A., Robert D. Trengove, Elaine M. Pascoe, et al.. (2016). Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology. 22(7). 548–554. 14 indexed citations
13.
Zhang, Lei, Jeff S. Coombes, Elaine M. Pascoe, et al.. (2015). The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial. Redox Report. 21(1). 14–23. 7 indexed citations
14.
Badve, Sunil V., Lei Zhang, Jeff S. Coombes, et al.. (2015). Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Canadian Journal of Kidney Health and Disease. 2. 33–33. 8 indexed citations
15.
Johnson, David W., Elaine M. Pascoe, Sunil V. Badve, et al.. (2014). A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial. American Journal of Kidney Diseases. 65(1). 49–57. 25 indexed citations
16.
Hawley, Carmel M., David W. Johnson, Sunil V. Badve, et al.. (2013). Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network. Kidney International. 85(1). 23–30. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026